Furthermore, recent evidence suggests that the NLRP3 inflammasome and its maturation of IL-18 downregulates the IL-22 binding protein, an inhibitor of IL-22, which promotes cell repair in inflammatory bowel diseases [51]. This evidence concerns the gene NLRP3 and inflammatory bowel disease.